NASH trials recruiting in Texas

All NASH trials nationally

Cities in Texas

Recruiting trials in Texas

• A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
  NCT07221188 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Texas: Austin, Brownsville, Dallas, DeSoto
• A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
  NCT07165028 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Austin, Bellaire, Brownsville, DeSoto
• A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
  NCT07527910 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Texas: Austin, Georgetown, San Antonio
• A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
  NCT07221227 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Texas: Arlington, Austin, Bellaire, Brownsville
• A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
  NCT05519475 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Texas: Austin, Brownsville, Cedar Park, Dallas
• A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
  NCT06528314 · Phase: Phase 3 · Ages: 18 Years to 80 Years · Sex: All (male and female) · Texas: Amarillo, Arlington, Austin, Bellaire
• A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
  NCT06215716 · Phase: Phase 3 · Ages: 18 Years to 80 Years · Sex: All (male and female) · Texas: Amarillo, Austin, Bellaire, Brownsville
• A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
  NCT06318169 · Phase: Phase 3 · Ages: 18 Years to 80 Years · Sex: All (male and female) · Texas: Amarillo, Austin, Bellaire, Brownsville
• A Study of Efimosfermin Alfa in Adults With Hepatic Impairment
  NCT07358546 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · Texas: San Antonio
• A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
  NCT06920043 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Texas: Austin, Dallas, Georgetown, Houston
• A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
  NCT07288138 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Texas: Austin, Bellaire, Brownsville, Corpus Christi
• A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
  NCT06419374 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Texas: Amarillo, Austin, Brownsville, DeSoto
• A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
  NCT05648214 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Texas: Houston
• Evaluating the Pharmacokinetics and Safety of Miricorilant
  NCT07553663 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Texas: San Antonio
• Evaluation of Non-Invasive Tests for Metabolic Liver Disease
  NCT07122700 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: All (male and female) · Texas: Bellaire, San Antonio
• LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
  NCT06632457 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Arlington, Austin, Bellaire, Brownsville
• LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
  NCT06632444 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Arlington, Austin, Bellaire, Brownsville
• NAFLD Clinical Care Pathway
  NCT06671886 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Texas: Houston
• Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
  NCT04054310 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · Texas: Dallas
• Quantifying Hepatic Mitochondrial Fluxes in Humans
  NCT05305287 · Phase: Phase 4 · Ages: 18 Years to 80 Years · Sex: All (male and female) · Texas: San Antonio